Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab

BACKGROUND: Immune-related adverse events associated with immune checkpoint therapy cause autoimmune disease-like symptoms. People who carry specific genotypes or haplotypes of human leucocyte antigen (HLA) are known to be predisposed to develop autoimmune diseases including narcolepsy. Immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Natori, Yutaka, Sasaki, Eisaku, Soeda, Shu, Furukawa, Shigenori, Azami, Yusuke, Tokuda, Emi, Kanbayashi, Takashi, Saji, Shigehira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534705/
https://www.ncbi.nlm.nih.gov/pubmed/33004543
http://dx.doi.org/10.1136/jitc-2020-001164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534705/
https://www.ncbi.nlm.nih.gov/pubmed/33004543
http://dx.doi.org/10.1136/jitc-2020-001164

Ejemplares similares